# Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness

> **NCT02148796** · PHASE2 · COMPLETED · sponsor: **University of Arizona** · enrollment: 822 (actual)

## Conditions studied

- Asthma
- Wheezing

## Interventions

- **DRUG:** Broncho-Vaxom (BV)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02148796
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2026-01-30
- **Final completion:** 2026-01-30
- **Target enrollment:** 822 (ACTUAL)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02148796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02148796, "Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02148796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*